Published 1 day ago • loading... • Updated 17 hours ago

Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting

In connection with MediPharm Labs’ 2025 Annual Meeting, Apollo Capital submitted a revised version of its dissident information circular to comply with applicable corporate and securities regulations.
The filing reflects Apollo Capital’s compliance with disclosure requirements outlined in NI 51-102 and utilizes a related provision under Ontario’s Business Corporations Act permitting public solicitation.
The circular includes disclosure about Apollo Capital’s director nominees and proxy revocation procedures under Ontario law, advising shareholders to read it carefully.
Apollo Capital engaged Carson Proxy Advisors with fees up to $250,000 and Gasthalter & Co. LP, which will receive at least US$75,000 plus a potential $250,000 performance fee if nominees secure a board majority.
Apollo Capital plans to recover its solicitation expenses from MediPharm to the fullest extent allowed by law, while emphasizing that all forward-looking statements reflect conditions solely as of the stated date.

Insights by Ground AI

Does this summary seem wrong?

11 Articles

All

Left

Center

Right

Waterloo Chronicle

+9 Reposted by 9 other sources

Lean Left

Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting

MediPharm Labs Board Continues to Obstruct the Appointment and Oversight of an Independent Chair

1 day ago·Waterloo, Canada

Read Full Article

ADKhabar

MediPharm Labs Cautions Shareholders about Dissident Nominees Governance Failures at Check-Cap Ltd.

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (“MediPharm”, the “Company”, or “we”), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with information related to three of the six directors (the “Dissident Nominees”) nominated by Apollo Technology Capital Corporation (“Apollo”) to stand for election at MediPharm’s Annual and […]

17 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year